Insider Transactions in Q1 2023 at Allovir, Inc. (ALVR)
Insider Transaction List (Q1 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 21
2023
|
Diana Brainard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,122
-0.55%
|
$30,732
$6.63 P/Share
|
Feb 02
2023
|
Diana Brainard Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
332,500
+26.23%
|
-
|
Feb 02
2023
|
Brett R Hagen Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,250
+31.17%
|
-
|
Feb 02
2023
|
Edward Miller General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
87,500
+27.05%
|
-
|
Feb 02
2023
|
Ann M. Leen Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
43,750
+26.08%
|
-
|
Feb 02
2023
|
Vikas Sinha |
BUY
Grant, award, or other acquisition
|
Direct |
157,500
+11.71%
|
-
|
Jan 20
2023
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
338
-0.45%
|
$1,690
$5.14 P/Share
|
Jan 20
2023
|
Edward Miller General Counsel |
SELL
Open market or private sale
|
Direct |
541
-0.36%
|
$2,705
$5.14 P/Share
|
Jan 20
2023
|
Vikas Sinha |
SELL
Open market or private sale
|
Direct |
1,426
-0.14%
|
$7,130
$5.14 P/Share
|
Jan 19
2023
|
Diana Brainard Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
34,435
-5.41%
|
$172,175
$5.08 P/Share
|
Jan 19
2023
|
Brett R Hagen Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,557
-2.05%
|
$7,785
$5.08 P/Share
|
Jan 19
2023
|
Edward Miller General Counsel |
SELL
Open market or private sale
|
Direct |
2,032
-1.35%
|
$10,160
$5.08 P/Share
|
Jan 19
2023
|
Vikas Sinha |
SELL
Open market or private sale
|
Direct |
5,111
-0.49%
|
$25,555
$5.08 P/Share
|